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Inductively coupled plasma mass spectrometry 
A B S T R A C T   
Background: Direct methods for the assessment of intra-erythrocyte magnesium (dIEM) require extensive sample 
preparation, making them labor intensive. An alternative, less labor intensive method is indirect calculation of 
intra-erythrocyte magnesium (iIEM). We compared dIEM and iIEM and studied determinants of dIEM and iIEM, 
plasma magnesium and 24-h urinary magnesium excretion in a large population-based cohort study. 
Methods: dIEM and iIEM were measured using a validated inductively coupled plasma mass spectrometry (ICP- 
MS) method in 1669 individuals from the second screening from the LifeLines Cohort Study. We used linear 
regression analyses to study the determinants of IEM, plasma magnesium and 24-h urinary magnesium excre-
tion. 
Results: Mean dIEM and iIEM were 0.20  ±  0.04 mmol/1012 cells and 0.25  ±  0.04 mmol/1012 cells, respec-
tively. We found a strong correlation between dIEM and iIEM (r = 0.75). Passing-Bablok regression analyses 
showed an intercept of 0.015 (95% CI: 0.005; 0.023) and a slope of 1.157 (95% CI: 1.109; 1.210). In linear 
regression analyses, plasma levels of total- and LDL -cholesterol, and triglycerides were positively associated 
dIEM, iIEM, and plasma magnesium, while glucose and HbA1c were inversely associated with plasma magne-
sium. 
Conclusions: We observed a strong correlation between dIEM and iIEM, suggesting that iIEM is a reliable al-
ternative for the labor intensive dIEM method.   
1. Introduction 
Magnesium is the second most abundant intracellular cation and is 
essential for regulation of many functions within the cell, including 
modulation of ion channels, protein synthesis and energy metabolism  
[1]. Of the total magnesium content in the human body, 55–65% is 
present in the skeleton, 34–44% in the intracellular space and only 
0.3–1% in the circulation [2,3]. 
We previously showed that lower plasma magnesium concentra-
tions were associated with increased risk of type 2 diabetes mellitus 
(T2DM) in women [4]. T2DM is characterized by disturbed glucose and 
lipid metabolism [5]. The effect of magnesium on insulin action could 
be one possible underlying mechanism by which magnesium affects 
diabetes risk, because the kinase function of the insulin receptors 
depends on the binding of two magnesium ions [6]. Thus, low in-
tracellular magnesium concentrations may lead to insulin resistance 
and decreased cellular glucose utilization [7]. Unfortunately, plasma 
magnesium has been shown to be a poor predictor of intracellular 
magnesium [8]. 
Several laboratory tests to assess cellular magnesium concentrations 
in the human body have been evaluated, of which measurements in 
leukocytes generally correlate well with other magnesium pools, in-
cluding skeleton, vascular smooth muscle and cardiac muscle [9]. 
However, concentrations of magnesium in leukocytes may vary ac-
cording to pathological states and study population [10]. 
An alternative approach to assess intracellular magnesium con-
centrations is the assessment of intra-erythrocyte magnesium (IEM), 
which can be done with direct (dIEM) [11,12] and indirect (iIEM) 
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methods [13]. Although the direct method has been suggested to be 
more accurate, this method requires labor-intensive sample preparation 
and high additional costs. Indirect methods, on the other hand, calcu-
late IEM concentrations based on whole blood and plasma magnesium, 
while accounting for hematocrit. So far, only one study evaluated direct 
and indirect methods for the assessment of IEM, however, using sam-
ples of 10 subjects [14]. 
In order to obtain a valid method comparison between dIEM and 
iIEM, we compared dIEM and iIEM in LifeLines, a large population- 
based cohort study in the northern part of the Netherlands. 
Furthermore, we studied correlations between dIEM, iIEM, plasma 
magnesium and 24-h urinary magnesium excretion and additionally 
investigated the determinants of these magnesium parameters. 
2. Material and methods 
2.1. Study participants 
Lifelines is a multi-disciplinary prospective population-based cohort 
study, examining in a unique three-generation design the health and 
health-related behaviors of 167,729 persons living in the North of The 
Netherlands. It employs a broad range of investigative procedures in 
assessing the biomedical, socio-demographic, behavioral, physical and 
psychological factors which contribute to the health and disease of the 
general population, with a special focus on multi-morbidity and com-
plex genetics [15]. In brief, participants were invited to participate 
through their general practitioner unless they met any of the following 
criteria: severe psychiatric or physical illness, limited life expectancy 
(< 5 years), and/or insufficient knowledge of the Dutch language to 
complete a Dutch questionnaire. 
For the present study, we used data from the second assessment that 
took place from 2014 until 2018. Within this second assessment, we 
collected blood and urine samples from August 2017 until December 
2017 in which we measured IEM, plasma magnesium and 24-h urinary 
magnesium excretion. In total, we included 1669 participants aged >  
18 years. All participants provided written informed consent. The 
Lifelines cohort study is conducted according to the principles of the 
Declaration of Helsinki and approved by the medical ethical committee 
of the University Medical Center Groningen, The Netherlands. 
2.2. Measurements of clinical parameters 
All participants visited the Lifelines research facility for a basic 
medical examination including blood pressure (ten times using a 
Dinamap automated blood pressure monitor), body height, weight (and 
body mass index (BMI)) and hip and waist circumference. Participants 
received oral and written instructions regarding the collection of 24-h 
urine [16]. Participants were instructed to postpone urine collection in 
case of urinary tract infection or menstruation, and to refrain as far as 
possible from heavy exercise during the collection period. On the day of 
collection, they were requested to discard the first morning urine, and 
to collect the subsequent urine for 24-h including the next morning’s 
urine. Urine and blood samples were collected for storage and labora-
tory measurements. Plasma glucose was measured routinely on a Cobas 
8000 platform (Roche, Mannheim, Germany) using a hexokinase UV 
test. Total cholesterol was measured using an enzymatic colorimetric 
assay, high-density lipoprotein cholesterol using a homogeneous en-
zymatic colorimetric assay, low-density lipoprotein cholesterol using a 
direct measurement, homogeneous enzymatic colorimetric assay, and 
triglycerides using a enzymatic colorimetric assay, not glycerol 
blanked, all measured routinely on a Cobas 8000 platform (Roche, 
Mannheim, Germany). Plasma sodium (indirect ISE) and potassium 
(indirect ISE) were measured routinely on a Cobas 8000 platform 
(Roche, Mannheim, Germany). Urine magnesium was measured on this 
platform as well, by means of the xylidyl blue colorimetric assay. 
Plasma and urine creatinine concentrations were determined using an 
Isotope Dilution Mass Spectrometry traceable enzymatic assay on a 
Roche Modular P analyzer [17]. Creatinine clearance was calculated 
using the following formula [18]: Creatinine clearance (ml/ 
min) = ((Ucreatinine * V)/Pcreatinine) * (1000/1440) in which Ucreatinine 
represents urinary creatinine concentration in μmol/L, V represent the 
24-hour urinary volume in liters and Pcreatinine represents plasma 
creatinine in μmol/L. Estimated glomerular filtration rate (eGFR) was 
estimated using the Chronic Kidney Disease Epidemiology Collabora-
tion equation (CKD-EPI), based on plasma creatinine [19]. eGFR was 
categorized into 2 groups: ≥90 ml/min/1.73 m2 and < 90 ml/min/ 
1.73 m2. HbA1c concentrations were measured on a Tosoh G8 (HPLC, 
Sysmex Corporation, Norderstedt, Germany). Hemoglobin, hematocrit, 
erythrocyte count, leukocytes, and mean corpuscular volume (MCV) 
were determined using a Sysmex XN20 automated hematology analyzer 
(Sysmex Corporation). 
Data on alcohol consumption and smoking status was obtained from 
questionnaires. Non-drinkers were defined as not having consumed 
alcohol during the past month. Individuals were classified into four 
groups according to their daily alcohol intake: 0 drinks/day (non- 
drinker), ≤1 drink/day (light drinker), > 1–2 drinks/day (moderate 
drinker) and > 2 drinks/day (heavy drinker) [20]. Smoking status was 
defined as self-reported non-smoker, former smoker or current smoker. 
2.3. Plasma magnesium assay 
The plasma magnesium concentration was assessed using a colori-
metric assay (Cobas 8000, Roche, Mannheim, Germany) at the 
University Medical Center Groningen. The colorimetric assay is based 
on the complex formation between magnesium ions and xylidyl blue in 
an alkaline solution (tris(hydroxymethyl)-aminomethane/6-aminoca-
proic acid buffer), forming a purple diazonium salt. The magnesium 
concentration is measured photometrically through the decrease in 
xylidyl blue absorbance. Ethylene glycol-bis(β-aminoethyl ether)- 
N,N,N′,N′-tetraacetic acid (EGTA) is added to mask the calcium ions 
present in the sample. The intra-assay and inter-assay coefficients of 
variation are 1.1% and 1.3% at 0.59 mmol/L, 0.8% and 1.1% at 
0.80 mmol/L and 0.7% and 0.9% at 1.35 mmol/L, respectively. 
2.4. Sample preparation 
EDTA whole blood samples were collected between August 2017 
until December 2017. One aliquot sample was prepared for iIEM and 
one for dIEM. Erythrocytes were isolated from plasma according to a 
strict protocol to obtain washed erythrocytes for dIEM. First, plasma 
and buffy coat layer were removed after centrifugation of EDTA whole 
blood samples at 428g for 10 min at 4 °C. The erythrocytes were washed 
using phosphate buffered saline (PBS). Samples were centrifuged (428g 
for 10 min at 4 °C) to separate the PBS from the erythrocytes. Finally, 
the supernatant PBS was removed after centrifugation. These steps were 
then performed again, so that each sample was washed twice with PBS. 
After washing, a part of the packed red blood cells was used for an 
erythrocyte count. The rest of the packed red blood cells were stored at 
−80 °C until thawed for testing. 
2.5. IEM assay 
Magnesium can be accurately quantified using a variety of analy-
tical techniques, including, but not limited to, atomic absorption 
spectrophotometry, particle-induced x-ray emission and inductively 
coupled plasma mass spectrometry (ICP-MS) [21]. An advantage of ICP- 
MS over other analytical techniques, such as atomic absorption spec-
trophotometry, is the lower limit of the detection [22]. In the present 
study, a validated ICP-MS method was used to determine magnesium in 
whole blood (for iIEM) and washed erythrocytes (for dIEM). The 
measurement of magnesium in serum and whole blood by an ICP-MS 
method has been previously validated [23]. However, the measurement 
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of IEM on an ICP-MS has not been validated before. Here, we describe 
the validation of magnesium in whole blood and washed erythrocytes 
on an ICP-MS in short that was performed at the University Medical 
Center Groningen. After mixing, 50 µl sample was diluted to 5 ml using 
a dilution reagent consisting of 0.1 mg/L Yttrium and 0.05% Triton- 
X100 and 0.05% EDTA in water. The diluted sample was measured with 
a Varian 820-ms ICP mass spectrometer. Six calibration standards, 
ranging from 5 to 50 mg/L were used and 3 quality control samples 
were measured with each run. The lower limit of quantitation was set to 
5 mg/L. All measured samples were above the lower limit of quanti-
tation. There were no matrix effects for whole blood or washed ery-
throcytes (equal slopes in different matrices) and calibration curve 
correlations were > 0.999. There were no significant interferences of 
other elements during the analyses. Accuracy was assessed at 4 con-
centration levels using Magnesium ICP-MS standard (VWR Chemicals, 
Radnor, Pennsylvania, US). For each concentration level, standards 
were measured 18 times over the course of 3 days. Bias was −3.2% at 
5 mg/L, 2.4% at 7.5 mg/L, 3.0% at 25 mg/L and 3.4% at 45 mg/L. 
Within run and between run coefficient of variation were 0.5% and 
2.0% for the LLOQ (5 mg/L), 0.6% and 2.7% for the low quality control 
sample (7.5 mg/L), 0.6% and 1.1% for the medium quality control 
sample (25.0 mg/L) and 0.4% and 0.8% for the high quality control 
sample (45 mg/L). iIEM was calculated according to the formula: 
iIEM = whole blood magnesium − (plasma magnesium × (1 − he-
matocrit))/hematocrit [14]. 
2.6. Statistical analyses 
Passing-Bablok regression analysis was used to calculate slopes and 
intercepts for the relationship between dIEM and iIEM (expressed in 
mmol/L and mmol/1012 cells). Bland-Altman plots were used to vi-
sualize and analyze bias between dIEM and iIEM. Data are presented as 
mean  ±  SD for normally distributed data and median [interquartile 
range (IQR)] for non-normally distributed data. Categorical data are 
presented as percentages. We used frequency distribution histograms 
and Q-Q plots to assess normality of our data. Data with a non-para-
metric distribution were log10 transformed. We tested correlations be-
tween dIEM, iIEM, plasma magnesium and 24-h urinary magnesium 
excretion with Pearson bivariate correlation coefficients. Linear re-
gression analysis was performed to investigate determinants of dIEM, 
iIEM, plasma magnesium and 24-h urinary magnesium excretion. 
Regression coefficients were given as standardized beta values, refer-
ring to the number of standard deviations a dependent variable changes 
per standard deviation increase of the independent variable, thereby 
allowing for comparison of the strength of the associations of different 
variables. Clinical parameters included BMI, waist circumference, glu-
cose concentrations, HbA1c, cholesterol and triglyceride concentra-
tions, blood pressure, renal function (eGFR and creatinine clearance), 
plasma concentrations of sodium and potassium and hematology 
parameters (hemoglobin, hematocrit, and MCV). Potential confounders, 
including age, sex, BMI, eGFR (eGFR  <  90 ml/min/1.73 m2), plasma 
sodium and potassium and alcohol consumption and smoking status 
were taken into account. Missing data (present in data on alcohol 
consumption (30.9%) and smoking status (30.4%)) were handled with 
multiple imputations [24]. Results are reported for imputed data, ex-
cept for the baseline characteristics. We evaluated potential effect 
modification in the associations of determinants with iIEM, dIEM, and 
plasma and urine magnesium by fitting models containing both main 
effects and their cross-product terms. Due to the shape of the cells, it is 
impossible to obtain only packed cells after washing and therefore, we 
indexed the intracellular magnesium concentrations to erythrocyte 
count and dIEM and iIEM were expressed as mmol/1012 cells. To study 
the robustness of the associations between determinants and dIEM and 
iIEM, we performed sensitivity analyses with dIEM and iIEM expressed 
as mmol per liter packed blood cells (Supplemental Table 3). A two- 
sided p  <  0.05 was considered to be statistical significant. Data ana-
lyses were performed using SPSS 25.0 for Windows (SPSS Inc., Chicago, 
IL) and Rstudio version 1.1.383 (Vienna, Austria). 
3. Results 
3.1. Baseline characteristics 
Baseline characteristics are shown in Table 1. Overall, mean age was 
51.0  ±  13.4 years, 57.5% were female, 36.0% were non-smoker and 
11.9% non-drinker. Mean BMI was 25.8  ±  4.3 kg/m2 and 32.2% of the 
participants had an eGFR  <  90 ml/min/1.73 m2. Finally, mean plasma 
magnesium was 0.85  ±  0.06 mmol/L and mean urinary magnesium 
excretion was 4.85  ±  1.76 mmol/24-h. 
Table 1 
Baseline characteristics of the LifeLines study.    
Characteristics Total 
(n = 1669)  
Age, years 51.0  ±  13.4 
Females, % 57.5 
Anthropometry  
Body mass index, kg/m2 25.8  ±  4.3 
Waist circumference, cm 89.9  ±  12.7 
Smoking statusa  
Non-smoker, % 36.0 
Former smoker, % 25.2 
Current smoker, % 8.3 
Alcohol consumptionb  
Non-drinker, % 11.9 
≤1 drink/day, % 38.3 
1–2 drinks/day, % 14.1 
≥2 drinks/day, % 4.7 
Magnesium parameters  
dIEM, mmol/1012 cells 0.20  ±  0.04 
iIEM, mmol/1012 cells 0.25  ±  0.04 
Plasma magnesium, mmol/L 0.85  ±  0.06 
Urinary magnesium excretion, mmol/24-h 4.85  ±  1.76 
Glucose metabolism  
Glucose, mmol/L 5.00 (4.70–5.40) 
HbA1c, mmol/mol 36.0 (34.0–38.0) 
Lipids metabolism  
Total cholesterol, mmol/L 5.01  ±  0.98 
LDL cholesterol, mmol/L 3.26  ±  0.90 
HDL cholesterol, mmol/L 1.49  ±  0.42 
Triglycerides, mmol/L 1.07 (0.77–1.51) 
Blood pressure  
Systolic, mm Hg 127  ±  17 
Diastolic, mm Hg 74  ±  9 
Renal parameters  
Plasma creatinine, µmol/L 80.2  ±  16.9 
Urinary creatinine excretion, mmol/24-h 13.3  ±  4.0 
eGFR  <  90 ml/min/1.73 m2, % 32.2 
Creatinine clearance, mL/min 116.5  ±  30.8 
Plasma levels  
Sodium, mmol/L 140.9  ±  1.7 
Potassium, mmol/L 4.01  ±  0.27 
Hematology  
Hemoglobin, mmol/L 8.80  ±  0.79 
Hematocrit, v/v 0.43  ±  0.03 
MCV, fL 89.0  ±  4.14 
Erythrocytes, 1012/L 4.79  ±  0.45 
Leukocytes, 109/L 6.08  ±  1.61 
Data are presented as mean  ±  SD, median with interquartile ranges (IQR) or 
percentages. Abbreviations: dIEM, direct intra-erythrocyte magnesium; iIEM, 
indirect intra-erythrocyte magnesium; eGFR, estimated glomerular filtration 
rate; HbA1c, hemoglobin A1c, MCV, mean corpuscular volume. 
a Available in 1161 subjects. 
b Available in 1153 subjects.  
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3.2. Method comparison 
We compared dIEM and iIEM in 1669 samples from the LifeLines 
study, both expressed as mmol per liter packed blood cells and mmol 
per 1012 red blood cells. Mean dIEM concentrations were 
1.73  ±  0.24 mmol/L and 0.20  ±  0.04 mmol/1012 cells and mean 
iIEM concentrations were 2.11  ±  0.24 mmol/L and 
0.25  ±  0.04 mmol/1012 cells. When expressed in magnesium per liter 
packed blood cell, we found a Pearson correlation coefficient of 0.57 
between dIEM and iIEM. Ordinary linear regression analysis produced 
an intercept of 1.092 (1.019; 1.164) and a slope of 0.590 (95% CI: 
0.549; 0.631) and Passing-Bablok regression produced an intercept of 
0.263 (95% CI: −0.156; 0.359) and a slope of 1.077 (95% CI: 1.019; 
1.142) (Fig. 1A). A Bland-Altman plot showed a systematic bias of 
0.44 mmol/L with iIEM being slightly higher as compared to dIEM 
(Fig. 1B). When expressed as magnesium per 1012 cells, a higher cor-
relation was observed between dIEM and iIEM (r = 0.75). Ordinary 
linear regression analysis produced an intercept of 0.078 (0.070; 0.085) 
and a slope of 0.836 (95% CI: 0.800; 0.872) and Passing-Bablok re-
gression produced an intercept of 0.015 (95% CI: 0.005; 0.023) and a 
slope of 1.157 (95% CI: 1.109; 1.210) (Fig. 1C). A Bland-Altman plot 
showed a systematic bias of 0.04 mmol/1012 cells with iIEM being 
slightly higher as compared to dIEM (Fig. 1D). 
3.3. Correlations between dIEM, iIEM, plasma magnesium and urinary 
magnesium excretion 
We found a positive correlation between plasma magnesium and 
dIEM (r = 0.18, P  <  0.001) (Fig. 2A). We observed no correlation 
between 24-h urinary magnesium excretion and dIEM (r = −0.002, 
P = 0.94) (Supplemental Fig. 2A). Similar correlations were found 
between plasma magnesium and iIEM (r = 0.14, P  <  0.001) (Fig. 2B) 
and 24-h urinary magnesium excretion and iIEM (r = 0.00, P = 1.00) 
(Supplemental Fig. 2B). Finally, 24-h urinary magnesium excretion was 
not correlated with plasma magnesium (r = 0.05, P = 0.07) 
(Supplemental Fig. 2C). 
Fig. 1. Passing-Bablok regression analysis for the method comparison and Blant-Altman plots to visualize bias expressed in mmol/L (A, B, respectively) and expressed 
in mmol/1012 cells (C, D, respectively). dIEM; direct intra-erythrocyte magnesium; iIEM; indirect intra-erythrocyte magnesium. 
Fig. 2. Scatterplots for the associations between plasma magnesium and dIEM 
(A), plasma magnesium and iIEM (B). dIEM; direct intra-erythrocyte magne-
sium, iIEM; indirect intra-erythrocyte magnesium. 
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3.4. Determinants of dIEM and iIEM 
Determinants of dIEM and iIEM are presented in Table 2. HbA1c 
was inversely associated with dIEM after adjustment for potential 
confounders. Among lipids, we found that higher total- and LDL cho-
lesterol and triglyceride concentrations were associated with higher 
dIEM, even after adjustment for potential confounders. Also, higher 
plasma concentrations of sodium and potassium were associated with 
higher dIEM. iIEM was positively associated with BMI, waist cir-
cumference, total- and LDL cholesterol, triglycerides, plasma sodium 
and potassium. Subgroup analyses are presented in Table 3. Higher age 
was associated with higher iIEM concentrations in females. Similar 
associations were found between the determinants and iIEM and dIEM 
expressed as mmol per liter packed blood cells (Supplemental Table 3). 
3.5. Determinants of plasma magnesium 
Determinants of plasma magnesium are shown in Table 2. BMI, as 
well as glucose and HbA1c were inversely associated with plasma 
magnesium. Higher total- and LDL- cholesterol and triglyceride con-
centrations, as well as higher diastolic blood pressure were associated 
with higher plasma magnesium concentrations. Finally, eGFR  <  
90 ml/min/1.73 m2 was associated with higher plasma magnesium 
concentrations. Subgroup analyses are presented in Table 3. Higher age 
was associated with higher plasma magnesium concentrations in fe-
males. In males, however, this association was found to be negative. 
The association of BMI with plasma magnesium was only present in 
older subjects (age ≥ 55 years). Furthermore, the association of HbA1c 
and plasma magnesium was stronger in males and older subjects 
(age ≥ 55 years). Subgroup analysis revealed that the positive asso-
ciation of triglycerides with plasma magnesium was only present in 
younger subjects (age  <  55 years). 
3.6. Determinants of 24-h urinary magnesium excretion 
Determinants of 24-h urinary magnesium excretion are presented in  
Supplemental Table 1. Females showed lower 24-h urinary magnesium 
excretion compared to males. HDL cholesterol, and plasma potassium 
were positively associated with 24-h urinary magnesium excretion. 
eGFR of < 90 ml/min/1.73 m2 was negatively associated with 24-h 
urinary magnesium excretion. Subgroup analyses are shown in  
Supplemental Table 2. BMI and waist circumference were inversely 
associated with 24-h urinary magnesium excretion only in older sub-
jects (age ≥ 55 years). In males, higher LDL cholesterol was associated 
with 24-h urinary magnesium excretion. The positive association of 
plasma potassium with 24-h urinary magnesium excretion was only 
present in younger subjects (age  <  55 years). 
4. Discussion 
Circulating magnesium (either plasma or serum) is still the most 
commonly used laboratory test for the assessment of magnesium status, 
despite only a small fraction of total body magnesium can be found in 
the circulation. Previous studies have shown that plasma magnesium 
concentrations correlate poorly with other magnesium tissue pools  
[2,8]. In fact, the body can suffer from severe magnesium deficiency 
while plasma magnesium concentrations are within the normal range  
[25]. Therefore, we believe that there is a need for a simple and rapid 
technique to measure intracellular magnesium concentrations. To the 
best of our knowledge, this is the first study to perform a method 
comparison between dIEM and iIEM in a large group of healthy parti-
cipants. The cardinal finding of this study is a strong correlation be-
tween dIEM and iIEM, with only a small degree of systematic and 
proportional bias. These findings indicate that iIEM can be used as a 
cheaper, less labor intensive alternative for dIEM. In addition, we found 
that dIEM and iIEM correlated with plasma magnesium, but not with 
24-h urinary magnesium excretion. Higher cholesterol and triglyceride 
concentrations were associated with higher dIEM, iIEM and plasma 
magnesium, while higher glucose and HbA1c were associated with 
lower plasma magnesium concentrations. 
dIEM requires extensive sample preparation, making it labor-in-
tensive which is accompanied by additional costs, and is therefore not 
suitable for routine laboratory measurements. Issues regarding labor- 
intensity and high costs of the dIEM were also reported by Deuster et al.  
[14]. Particularly, obtaining erythrocytes by means of a washing pro-
cedure is time consuming and involves extra costs. In our case, it re-
quired two technicians for three hours to prepare fifty samples for 
dIEM, whereas for iIEM, the same amount of samples could be prepared 
by one technician in approximately twenty minutes, which makes the 
sample preparation of dIEM eighteen times more labor-intensive. 
Overall, personnel costs were four times higher for dIEM, whereas costs 
for material and additional measurements were comparable between 
the methods. Altogether, we estimate the total costs of dIEM to be al-
most twice as high as the total costs of iIEM (US$6.95 per sample vs. US 
$3.54 per sample, respectively). Thus, iIEM is a simple, rapid, and less 
expensive technique, which only requires measurement of hematocrit 
and magnesium in plasma and whole blood, and can therefore be em-
bedded in current routine of clinical measurements. So far, only one 
study compared dIEM and iIEM [14]. However, they included only a 
small group of men and women (n = 10). The systematic bias that we 
observed can be attributable to the washing process. Removing all the 
supernatant PBS from the samples after centrifugation is difficult and 
requires precision. However, despite the accuracy of the personnel, 
some PBS could have remained in the samples, which explains the 
systematic bias and subsequently, the lower concentrations measured 
by the direct method. The fact that the systematic bias is much lower 
after adjusting for erythrocyte count supports this hypothesis. The ad-
vantages of the indirect method, including lower costs and lower labor 
intensity, outweigh the relative small bias that was observed. 
In a randomized controlled trial, the effect of magnesium supple-
mentation on IEM concentrations was studied. They showed that after a 
magnesium supplementation period of 3 weeks in women with low IEM 
concentrations (< 1.97 mmol/L), plasma magnesium and 24-h urinary 
magnesium excretion were significantly increased, but no significant 
increase was found in IEM concentrations [26]. The authors concluded 
that low IEM concentrations may not reflect systemic magnesium de-
ficiency, but rather the activity of metabolic determinants, such as the 
Na+/Mg2+ exchanger [27]. However, the supplementation period of 
3 weeks might have been too short to detect differences in erythrocytes 
concentrations of magnesium. In the present study, dIEM, iIEM and 
plasma magnesium were not correlated with 24-h urinary magnesium 
excretion, as estimate of dietary absorption, suggesting that dietary 
magnesium intake is not directly reflected in the circulation and in 
cells, at least not in erythrocytes. 
Evidence regarding involvement of magnesium in glucose and in-
sulin metabolism is accumulating [7]. Previous studies showed that 
lower circulating magnesium concentrations were associated with in-
creased risk of T2DM in the general population [4,28]. Furthermore, 
long-term magnesium supplementation improved insulin sensitivity in 
T2DM patients [29], suggesting that the previously found associations 
are causal in nature. Magnesium concentrations in plasma, as well as 
concentrations in erythrocytes and platelets, were lower in diabetic 
patients and were even more reduced in diabetic patients with hy-
pertension [30,31]. We therefore hypothesized that glucose and HbA1c 
are inversely associated with IEM and plasma magnesium concentra-
tions because of its potential to stimulate cellular glucose utilization. In 
the present study, higher glucose and HbA1c were independently as-
sociated with lower plasma magnesium concentrations. This is in line 
with previous studies in diabetic patients [32,33] and also with our 
recent findings in the general population [4,34]. Although glucose and 
HbA1c were inversely associated with plasma magnesium, we have not 
observed such associations with IEM. Our findings may indicate that 
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plasma magnesium, rather than IEM, is involved in glucose metabolism. 
However, future studies, preferable in patients with T2DM who are at 
risk of hypomagnesaemia, should further elucidate whether in-
tracellular concentrations of magnesium are associated with glucose 
and insulin metabolism. The observed positive associations of choles-
terol and triglycerides with IEM and plasma magnesium remain diffi-
cult to explain. Recently, Waanders et al. studied determinants of hy-
pomagnesemia in diabetic patients and found that higher LDL 
cholesterol concentrations, but not triglycerides, were associated with 
higher plasma magnesium concentrations [33]. Furthermore, serum 
magnesium was also positively associated with lipoproteins in a large 
cohort study including healthy individuals [35]. The authors speculated 
that the positive association might be explained by a binding interac-
tion between serum magnesium and lipoprotein particles. An eGFR 
below 90 ml/min/1.73 m2 was associated with increased plasma 
magnesium concentrations as well as with decreased 24-h urinary 
magnesium excretion. Indeed, it is known that in patients with end 
stage renal disease, plasma magnesium concentration may slightly in-
crease as a consequence of a reduced glomerular filtration rate [36]. In 
the present study, eGFR was not associated with IEM. Finally, IEM was 
positively associated with age in current study and this association re-
mained significant after adjustment for potential confounders. Inter-
estingly, a previous study found the opposite; intra-erythrocyte mag-
nesium was inversely associated with age [37]. We found no association 
between age and plasma magnesium. 
It should be noted that this study found several differential asso-
ciations of dIEM and iIEM with their determinants. Most notably, the 
association with female sex was stronger with iIEM than with dIEM. 
Similarly, iIEM also associated more strongly with BMI. These findings 
implicate that, compared to dIEM, iIEM may lead to higher values in 
females and in obese participants. On the other hand, the association 
with plasma potassium was stronger with dIEM. Thus, dIEM may yield 
higher values in participants with higher plasma potassium con-
centrations. A few limitations should be addressed. The main limitation 
is that we were unable to demonstrate cause-effect relationships be-
tween magnesium concentrations and clinical features. However, low 
circulating magnesium concentrations and low urinary magnesium 
excretions at baseline have been previously associated with increased 
risk of hypertension [38], and ischemic heart disease [39]. Second, 
previous studies suggested that magnesium is involved in both glucose 
and insulin metabolism. Unfortunately, insulin was not measured in our 
cohort and therefore, we are unable to draw conclusions regarding 
associations between insulin and magnesium. In addition, no data on 
dietary magnesium intake was available. Instead, however, we used 24- 
h urinary magnesium excretion as a measure of intestinal absorption  
[40]. Finally, our cohort consists predominantly of Caucasians (98.7%), 
which limits external validity of our results. 
This study has several strengths. This is the first study that com-
pared two methods for the assessment of IEM in a large population- 
based cohort study. The measurement of intracellular magnesium has 
become more popular nowadays and therefore, there is a need for a 
simple and rapid technique to measure intracellular concentrations 
without labor-intensive sample preparations. In addition, we used a 
large cohort study including extensive clinical and biochemical char-
acterization of our subjects to explore associations of clinical para-
meters with IEM, plasma magnesium and 24-h urinary magnesium 
excretion. 
5. Conclusions 
In conclusion, we found a strong correlation between a direct and an 
indirect method for the assessment of IEM. Our study indicates that 
iIEM can be used in practice, eliminating labor-intensive washing 
procedures and high costs required for direct methods. Furthermore, 
the advantages of iIEM, including lower costs and lower labor intensity, 
outweigh the relative small bias that was found. Associations between 
clinical parameters and IEM need to be further explored in well-de-
signed randomized clinical trials and large cohort studies, preferable in 
study populations that are prone to hypomagnesemia and in which IEM 
concentrations might be depleted, such as T2DM patients or kidney 
transplant recipients. 
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